Q1 2018 |
59 |
$133M |
+$48.2M |
-$66.2M |
-$18M |
ESPR, IMMU, GBT, HUM, BIIB
|
13F-HR |
5/15/2018, 04:13 PM |
Q4 2017 |
59 |
$151M |
+$30.2M |
-$58.2M |
-$28M |
ESPR, CELG, IMMU, BIIB, HUM
|
13F-HR |
2/14/2018, 04:32 PM |
Q3 2017 |
63 |
$175M |
$0 |
$0 |
|
CELG, ESPR, IMMU, CLVSQ, BIIB
|
New Holdings |
11/16/2017, 11:10 AM |
Q3 2017 |
63 |
$175M |
+$57.2M |
-$50.1M |
+$7.09M |
CELG, ESPR, IMMU, CLVSQ, BIIB
|
13F-HR |
11/14/2017, 04:31 PM |
Q2 2017 |
54 |
$156M |
+$41.4M |
-$60.8M |
-$19.4M |
CELG, ALXN, CLVSQ, SHPG, AGN
|
13F-HR |
8/14/2017, 05:01 PM |
Q1 2017 |
60 |
$179M |
+$52.8M |
-$52.7M |
+$65.5K |
MDCO, CELG, SHPG, AMGN, MRK
|
13F-HR |
5/15/2017, 05:20 PM |
Q4 2016 |
54 |
$156M |
+$31.7M |
-$113M |
-$81.8M |
RARE, BIIB, MDCO, CELG, AMGN
|
13F-HR |
2/14/2017, 04:06 PM |
Q3 2016 |
65 |
$251M |
$0 |
$0 |
|
RARE, BIIB, SHPG, CLVSQ, ZBH
|
New Holdings |
11/17/2016, 03:36 PM |
Q3 2016 |
65 |
$251M |
+$74.7M |
-$72.4M |
+$2.29M |
RARE, BIIB, SHPG, CLVSQ, ZBH
|
13F-HR |
11/14/2016, 05:03 PM |
Q2 2016 |
69 |
$217M |
+$81.7M |
-$92.7M |
-$11M |
CELG, ZBH, GILD, SHPG, ELV
|
Restatement |
11/4/2016, 04:05 PM |
Q1 2016 |
59 |
$214M |
+$96.6M |
-$106M |
-$9.15M |
CELG, CI, MDVN, BAX, ZBH
|
Restatement |
5/24/2016, 01:24 PM |
Q4 2015 |
59 |
$260M |
+$120M |
-$84.8M |
+$35M |
CELG, CI, AMGN, RARE, BAX
|
13F-HR |
2/16/2016, 04:23 PM |
Q3 2015 |
61 |
$213M |
+$70.6M |
-$61M |
+$9.53M |
ELV, VRX, RARE, GILD, CELG
|
13F-HR |
11/16/2015, 04:14 PM |
Q2 2015 |
54 |
$246M |
+$103M |
-$103M |
-$320K |
RARE, CELG, ESPR, GILD, AMGN
|
13F-HR |
8/14/2015, 04:28 PM |
Q1 2015 |
62 |
$235M |
+$124M |
-$84.1M |
+$40.1M |
PFE, ESPR, CELG, RARE, GILD
|
Restatement |
6/10/2015, 01:48 PM |
Q4 2014 |
48 |
$181M |
+$46.2M |
-$50.4M |
-$4.27M |
BIIB, CELG, GILD, MDT, XLRN
|
13F-HR |
2/17/2015, 07:10 PM |
Q3 2014 |
51 |
$166M |
+$50.7M |
-$59.1M |
-$8.35M |
BIIB, GILD, AMGN, MDT, ABBV
|
13F-HR |
11/14/2014, 04:39 PM |
Q2 2014 |
50 |
$166M |
+$56.3M |
-$52.8M |
+$3.52M |
BIIB, AMGN, MDT, CELG, MRK
|
13F-HR |
8/14/2014, 04:17 PM |
Q1 2014 |
50 |
$160M |
+$63.9M |
-$38.1M |
+$25.8M |
BIIB, AMGN, MRK, CI, ZBH
|
13F-HR |
5/16/2014, 12:55 PM |
Q4 2013 |
52 |
$130M |
$0 |
$0 |
|
AMGN, MRK, BIIB, ZBH, GILD
|
13F-HR |
2/14/2014, 04:43 PM |